Author/Authors :
DA Aitken، نويسنده , , EM Wallace، نويسنده , , JA Crossley، نويسنده , , IA Swanston، نويسنده , , Y van Pareren، نويسنده , , Merel C. van Maarle، نويسنده ,
Abstract :
A new marker, dimeric inhibin A, was tested to determine its effectiveness in screening for Down syndrome in the second trimester of pregnancy. The test was performed at 7-18 weeks of gestation in 58 women with an affected fetus (Down syndrome) and in 438
